Caffeine — The Adenosine Antagonist
Caffeine is a widely consumed methylxanthine stimulant that acts primarily by antagonizing adenosine receptors. Beyond its cognitive and metabolic benefits, regular consumption (often via coffee) is consistently associated with reduced all-cause mortality and improved healthspan in large epidemiological studies.
Mechanism of Action
Caffeine primarily acts as a non-selective antagonist of adenosine receptors (A1 and A2A) in the central nervous system, preventing adenosine-induced drowsiness. Beyond its stimulant effects, caffeine has been shown to activate AMPK, a key cellular energy sensor, which subsequently inhibits the mTOR pathway and promotes autophagy. It also increases intracellular calcium release, which can further stimulate AMPK-dependent glucose uptake in skeletal muscle.
Human Trial Evidence
Multiple large prospective cohort studies, including the UK Biobank and NIH-AARP Diet and Health Study, demonstrate an inverse association between coffee consumption and all-cause mortality. These benefits appear independent of genetic variations in caffeine metabolism. However, these are observational studies on coffee rather than randomized controlled trials of isolated caffeine for longevity.
Dosing Protocol
Up to 400 mg/day is considered safe for most adults, typically consumed as 2–4 cups of brewed coffee. The half-life of caffeine is approximately 4–6 hours, so intake is best limited to the morning and early afternoon to avoid sleep disruption.
Safety & Contraindications
Common adverse effects include insomnia, jitteriness, tachycardia, and gastrointestinal distress at high doses. It should be used with caution in individuals with severe anxiety, uncontrolled hypertension, or arrhythmias. Pregnant women are generally advised to limit intake to under 200 mg/day.